DIGITAL EDITION

ARCHIVES

Category: Departments

It’s Nice to Be Nice, But…A Little Risk Management Can Go a Long Way in Reducing Your Liability Risk

by Donna Vanderpool, MBA, JD Ms. Vanderpool is Vice President at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: The author

Letter to the Editor: When “Cure” becomes “Care” in Robotic Neurorehabilitation: The Critical Role of Nurses in a Novel Sicilian Multidisciplinary Approach

By Alfredo Manuli, MSc, and Rocco Salvatore Calabrò, MD, PhD Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received

Letter to the Editor: The Ever-changing Landscape of the Opioid Crisis: Fentanyl and its Analogs

By Adegboyega Oyemade, MD, FAPA Funding/financial disclosures. The author has no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this

Editorial Message and Issue Highlights–Vol. 15, No. 9–10, September-October 2018

Dear Colleagues: Welcome to the September–October 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a systematic review by Bart et al titled, “The Assessment and

The Assessment and Measurement of Wellness in the Clinical Medical Setting: A Systematic Review

by Ryan Bart, DO; Waguih William IsHak, MD, FAPA; Shaina Ganjian, MS; Karim Yahia Jaffer; Marina Abdelmesseh, MD, CIC; Sophia Hanna, BA; Yasmine Gohar, BA; Gezelle Azar, Bs; Brigitte Vanle,

Does Vitamin D Deficiency Contribute to Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus?

by Hoda A. Hussein, MD; Lamiaa I. Daker, MD; Nermeen A. Fouad, MD; Azza Elamir, MD; and Shereen R. Mohamed, MD Dr. Hussein is with the Internal Medicine Department, Dr.

Risk Management: My Patient Suicided, Now What?

by Donna Vanderpool, MBA, JD Ms. Vanderpool is Vice President at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: The author

Letter to the Editor: Looking Beyond the Obvious: Non-motor Parkinsonism

By Shivani Naik, MD; Murali Kolikonda, MD; Shanti Pittampalli, MD; Steven Lippmann, MD Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No

Letter to the Editor: Gait Rehabilitation following Neurological Disorders: Are Robotic Devices the Future?

By Rocco Salvatore Calabrò, MD, PhD; Alfredo Manuli, MSc; Antonino Leo, MSc; Margherita Russo, MD, PhD; Antonino Naro, MD, PhD; and Placido Bramanti, MD IRCCS Centro Neurolesi “Bonino-Pulej0,” Messina, Italy

The Neuroscience Report—Vol. 53 (August 14, 2018): Binge Eating Disorders

Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5

Editorial Message and Issue Highlights–Vol. 15, No. 7–8, July-August 2018

Dear Colleagues: Welcome to the July–August 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a report by Brennan et al titled, “Implementation of the Electronic

Worsening Choreoathetosis in Huntington’s Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report

By Clayton J. Hamilton, PharmD; Tysen K. Timmer, BA; Robert C. Munjal, MD; Fernando Cardozo-Pelaez, PhD; and Ian R. McGrane, PharmD Dr. Hamilton is with the Department of Pharmacy, Veteran’s

Atypical Neuroleptic Malignant Syndrome Precipitated By Clozapine And Quetiapine Overdose: A Diagnostic Challenge

By David Choon Liang Teo, MBBS, MRC Psych (UK), FAMS (Psychiatry); Hon Khuan Wong, MBBS; Sheng Neng Tan, MBBS, MMED (Psychiatry), FAMS (Psychiatry) Drs. Teo, Wong and Tan are with

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

By Edmund G. Howe, MD, JD; Laney Rosenzweig, MS, LMRT; and Amy Shuman, MSW, LICSW, DCSW Dr. Howe is Professor of Psychiatry and Medicine, Uniformed Services University of the Health

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

By Clare Brennan, DPT, MSPH; Hannah Whillis, MS; Choy Man, BS; Brian Wynne, MD; Vani Vannappagari, MBBS, MPH, PhD Dr. Brennan and and Ms. Man are with Clinical Development and

Risk Management: Licensing Board Complaints: What You Need To Know

By Ann McNary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: The authors

Letter to the Editor: Metabolic Changes in Patients with Schizophrenia Switched from Olanzapine to Asenaprine or Clozapine

By Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Funding/financial disclosures: The author has no conflicts of interest relevant to the content of this letter. No funding was received